Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis.

Ther Adv Med Oncol · 2018 · PMC6080081 · PMID 30093922

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Data on PPS available from 22 treatment comparisons showed a trend to an increasing median PPS over time for both the experimental ( P trend = 0.03) and control arms ( P trend = 0.003) [ Figure 3(a) ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.